Souris de lignée NOD : Questions médicales fréquentes
Nom anglais: Mice, Inbred NOD
Descriptor UI:D016688
Tree Number:B01.050.150.900.649.313.992.635.505.500.400.565
Termes MeSH sélectionnés :
Colonic Polyps
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Souris de lignée NOD : Questions médicales les plus fréquentes",
"headline": "Souris de lignée NOD : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Souris de lignée NOD : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Souris de lignée NOD"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lignées consanguines de souris",
"url": "https://questionsmedicales.fr/mesh/D008815",
"about": {
"@type": "MedicalCondition",
"name": "Lignées consanguines de souris",
"code": {
"@type": "MedicalCode",
"code": "D008815",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.050.150.900.649.313.992.635.505.500.400"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Souris de lignée NOD",
"alternateName": "Mice, Inbred NOD",
"code": {
"@type": "MedicalCode",
"code": "D016688",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Helen E Thomas",
"url": "https://questionsmedicales.fr/author/Helen%20E%20Thomas",
"affiliation": {
"@type": "Organization",
"name": "St. Vincent's Institute, Fitzroy, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Aline Dionizio",
"url": "https://questionsmedicales.fr/author/Aline%20Dionizio",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Al. Octávio Pinheiro Brisolla, 9-75, 17012-901 Bauru, São Paulo, Brazil."
}
},
{
"@type": "Person",
"name": "Vivek M Philip",
"url": "https://questionsmedicales.fr/author/Vivek%20M%20Philip",
"affiliation": {
"@type": "Organization",
"name": "The Jackson Laboratory, Bar Harbor, ME, USA."
}
},
{
"@type": "Person",
"name": "John P Sundberg",
"url": "https://questionsmedicales.fr/author/John%20P%20Sundberg",
"affiliation": {
"@type": "Organization",
"name": "3 The Jackson Laboratory, Bar Harbor, ME, USA."
}
},
{
"@type": "Person",
"name": "Virginia R Aldrich",
"url": "https://questionsmedicales.fr/author/Virginia%20R%20Aldrich",
"affiliation": {
"@type": "Organization",
"name": "Diabetes Research Institute and Cell Transplant Center, University of Miami Miller School of Medicine, Miami, FL, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Polyp characterization using deep learning and a publicly accessible polyp video database.",
"datePublished": "2023-01-18",
"url": "https://questionsmedicales.fr/article/36527309",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/den.14500"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of diverse colorectal polyps and risk factors for colorectal carcinoma in situ and neoplastic polyps.",
"datePublished": "2024-04-17",
"url": "https://questionsmedicales.fr/article/38632639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05111-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use.",
"datePublished": "2023-07-30",
"url": "https://questionsmedicales.fr/article/37518954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/apt.17646"
}
},
{
"@type": "ScholarlyArticle",
"name": "G-EYE Improves Polyp, Adenoma, and Serrated Polyp Detection Rates in Colonoscopy: A Systematic Review and Meta-analysis.",
"datePublished": "2024-08-01",
"url": "https://questionsmedicales.fr/article/38967382",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MCG.0000000000001924"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of nonalcoholic fatty liver disease with colorectal adenomatous polyps and non-adenomatous polyps: a cross-sectional study.",
"datePublished": "2023-08-22",
"url": "https://questionsmedicales.fr/article/37642651",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MEG.0000000000002636"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Animaux",
"item": "https://questionsmedicales.fr/mesh/D000818"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chordés",
"item": "https://questionsmedicales.fr/mesh/D043344"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vertébrés",
"item": "https://questionsmedicales.fr/mesh/D014714"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mammifères",
"item": "https://questionsmedicales.fr/mesh/D008322"
},
{
"@type": "ListItem",
"position": 7,
"name": "Eutheria",
"item": "https://questionsmedicales.fr/mesh/D000073566"
},
{
"@type": "ListItem",
"position": 8,
"name": "Rodentia",
"item": "https://questionsmedicales.fr/mesh/D012377"
},
{
"@type": "ListItem",
"position": 9,
"name": "Muridae",
"item": "https://questionsmedicales.fr/mesh/D009115"
},
{
"@type": "ListItem",
"position": 10,
"name": "Murinae",
"item": "https://questionsmedicales.fr/mesh/D051189"
},
{
"@type": "ListItem",
"position": 11,
"name": "Souris",
"item": "https://questionsmedicales.fr/mesh/D051379"
},
{
"@type": "ListItem",
"position": 12,
"name": "Lignées consanguines de souris",
"item": "https://questionsmedicales.fr/mesh/D008815"
},
{
"@type": "ListItem",
"position": 13,
"name": "Souris de lignée NOD",
"item": "https://questionsmedicales.fr/mesh/D016688"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Souris de lignée NOD - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Souris de lignée NOD",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Souris de lignée NOD",
"description": "Comment diagnostiquer le diabète chez les souris NOD ?\nQuels tests sont utilisés pour évaluer l'auto-immunité ?\nQuels signes cliniques indiquent un diabète chez les souris NOD ?\nÀ quel âge les souris NOD développent-elles le diabète ?\nComment évaluer la fonction pancréatique chez les souris NOD ?",
"url": "https://questionsmedicales.fr/mesh/D016688?mesh_terms=Colonic+Polyps&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Souris de lignée NOD",
"description": "Quels sont les symptômes du diabète chez les souris NOD ?\nComment reconnaître la polydipsie chez les souris NOD ?\nLes souris NOD montrent-elles des signes de neuropathie ?\nQuels changements comportementaux sont observés ?\nLes souris NOD présentent-elles des complications oculaires ?",
"url": "https://questionsmedicales.fr/mesh/D016688?mesh_terms=Colonic+Polyps&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Souris de lignée NOD",
"description": "Peut-on prévenir le diabète chez les souris NOD ?\nQuel rôle joue l'environnement dans la prévention ?\nLes interventions immunologiques sont-elles efficaces ?\nComment le suivi génétique aide-t-il à la prévention ?\nLes vaccins peuvent-ils prévenir le diabète ?",
"url": "https://questionsmedicales.fr/mesh/D016688?mesh_terms=Colonic+Polyps&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Souris de lignée NOD",
"description": "Quels traitements sont utilisés pour les souris NOD diabétiques ?\nComment l'alimentation influence-t-elle le diabète chez les souris NOD ?\nLes traitements immunosuppresseurs sont-ils efficaces ?\nComment la thérapie génique est-elle utilisée ?\nQuels sont les effets des traitements à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D016688?mesh_terms=Colonic+Polyps&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Souris de lignée NOD",
"description": "Quelles sont les complications courantes du diabète chez les souris NOD ?\nComment le diabète affecte-t-il les reins des souris NOD ?\nLes souris NOD développent-elles des maladies cardiovasculaires ?\nQuels sont les effets de l'hyperglycémie prolongée ?\nComment prévenir les complications chez les souris NOD ?",
"url": "https://questionsmedicales.fr/mesh/D016688?mesh_terms=Colonic+Polyps&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Souris de lignée NOD",
"description": "Quels sont les facteurs génétiques de risque chez les souris NOD ?\nL'alimentation influence-t-elle le risque de diabète ?\nLe stress environnemental est-il un facteur de risque ?\nLes infections jouent-elles un rôle dans le diabète ?\nL'âge est-il un facteur de risque pour les souris NOD ?",
"url": "https://questionsmedicales.fr/mesh/D016688?mesh_terms=Colonic+Polyps&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le diabète chez les souris NOD ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par mesure de la glycémie et évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'auto-immunité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques pour détecter les anticorps anti-insulines sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un diabète chez les souris NOD ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent polyurie, polydipsie et perte de poids significative."
}
},
{
"@type": "Question",
"name": "À quel âge les souris NOD développent-elles le diabète ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète se développe généralement entre 3 et 5 mois chez les souris NOD."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction pancréatique chez les souris NOD ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests de tolérance au glucose pour évaluer la fonction pancréatique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du diabète chez les souris NOD ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent hyperglycémie, perte de poids, et léthargie."
}
},
{
"@type": "Question",
"name": "Comment reconnaître la polydipsie chez les souris NOD ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La polydipsie se manifeste par une consommation excessive d'eau et une soif accrue."
}
},
{
"@type": "Question",
"name": "Les souris NOD montrent-elles des signes de neuropathie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent développer des signes de neuropathie diabétique, comme des troubles moteurs."
}
},
{
"@type": "Question",
"name": "Quels changements comportementaux sont observés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les souris peuvent devenir moins actives et montrer des signes de dépression."
}
},
{
"@type": "Question",
"name": "Les souris NOD présentent-elles des complications oculaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent développer des cataractes et d'autres complications oculaires liées au diabète."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le diabète chez les souris NOD ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions précoces, comme des modifications alimentaires, peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement contrôlé peut diminuer le stress et l'incidence du diabète."
}
},
{
"@type": "Question",
"name": "Les interventions immunologiques sont-elles efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent moduler la réponse immunitaire et retarder l'apparition du diabète."
}
},
{
"@type": "Question",
"name": "Comment le suivi génétique aide-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le suivi génétique permet d'identifier les souris à risque et d'adapter les soins."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir le diabète ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les vaccins pour prévenir le diabète auto-immun."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour les souris NOD diabétiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuline et les médicaments antidiabétiques oraux sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle le diabète chez les souris NOD ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation contrôlée peut aider à gérer la glycémie et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire l'auto-immunité et améliorer la fonction pancréatique."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique est-elle utilisée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique vise à corriger les défauts immunitaires et à restaurer la fonction pancréatique."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des traitements à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements à long terme peuvent améliorer la qualité de vie mais nécessitent un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes du diabète chez les souris NOD ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la neuropathie, la néphropathie et les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment le diabète affecte-t-il les reins des souris NOD ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète peut entraîner une néphropathie diabétique, affectant la fonction rénale."
}
},
{
"@type": "Question",
"name": "Les souris NOD développent-elles des maladies cardiovasculaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont à risque accru de maladies cardiovasculaires en raison de l'hyperglycémie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets de l'hyperglycémie prolongée ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperglycémie prolongée peut causer des dommages aux organes et des complications graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications chez les souris NOD ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un contrôle glycémique rigoureux et des soins vétérinaires réguliers aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs génétiques de risque chez les souris NOD ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les souris NOD présentent des prédispositions génétiques à développer le diabète."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de diabète ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en glucides peut augmenter le risque de diabète chez les souris."
}
},
{
"@type": "Question",
"name": "Le stress environnemental est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les réponses immunitaires et augmenter le risque de diabète."
}
},
{
"@type": "Question",
"name": "Les infections jouent-elles un rôle dans le diabète ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent déclencher des réponses auto-immunes, augmentant le risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les souris NOD ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de diabète augmente avec l'âge chez les souris NOD, généralement après 3 mois."
}
}
]
}
]
}
Convolutional neural networks (CNN) for computer-aided diagnosis of polyps are often trained using high-quality still images in a single chromoendoscopy imaging modality with sessile serrated lesions ...
We trained a CNN with 16,832 high and moderate quality frames from 229 polyp videos (56 SSLs). It was evaluated with 222 polyp videos (36 SSLs) across two test-sets. Test-set I consists of 14,320 fram...
Sensitivity for adenoma characterization was 91.6% in test-set I and 89.7% in test-set II. Specificity was 91.9% and 88.5%. Sensitivity for diminutive polyps was 89.9% and 87.5%; specificity 90.5% and...
A single CNN can differentiate adenomas from SSLs and hyperplastic polyps in both NBI and NBI-NF. A publicly accessible NBI polyp video database was created and benchmarked....
Most colorectal cancers originate from precancerous polyps. This study aimed to determine the prevalence of colorectal polyps with diverse pathological morphologies and to explore the risk factors for...
Inpatients admitted from January 2018 to May 2023 were screened through the hospital information system. Polyps were classified according to pathological morphology. The prevalence of polyps was descr...
In total, 2329 individuals with 3550 polyps were recruited. Among all patients, 76.99% had neoplastic polyps and 44.31% had advanced adenomas. Tubular adenoma had the highest prevalence at 60.15%, and...
More than 3/4 of colorectal polyp patients have neoplastic polyps. Patients are more inclined to develop CCS and neoplastic polyps if they have large polyps (> 1.0 cm) or multifocal polyps. The levels...
The seAFOod polyp prevention trial was a randomised, placebo-controlled, 2 × 2 factorial trial of aspirin 300 mg and eicosapentaenoic acid (EPA) 2000 mg daily in individuals who had a screening colono...
To investigate colorectal polyp risk according to the original trial treatment allocation, up to 6 years after trial participation....
All seAFOod trial participants were scheduled for further BCSP surveillance and provided informed consent for the collection of colonoscopy outcomes. We linked BCSP colonoscopy data to trial outcomes ...
In total, 507 individuals underwent one or more colonoscopies after trial participation. Individuals grouped by treatment allocation were well matched for clinical characteristics, follow-up duration ...
Individuals who received aspirin in the seAFOod trial demonstrated increased colorectal polyp risk during post-trial surveillance. Rebound elevated neoplastic risk after short-term aspirin use has imp...
Colonoscopy is the gold-standard test to decrease mortality from colorectal cancer (CRC). G-EYE is an inflated balloon on the bending section of the scope with the ability to flatten the folds to impr...
A literature search was performed through March 21, 2023, on databases including Embase, Medline, Cochrane Central Register of Controlled Trials, Web of Science Core Collection, KCI-Korean Journal Ind...
The search strategy yielded a total of 143 articles. Three studies with 3868 total colonoscopies were finalized. The pooled ADR, PDR, and SPDR showed statistical improvement with G-EYE (OR: 1.744, 95%...
This meta-analysis suggests that G-EYE can improve ADR, PDR, and SPDR. Further studies are needed to evaluate the effect of G-EYE on interval CRC and mortality rate....
This study aimed to investigate the association between non-alcoholic fatty liver disease (NAFLD) and both colorectal adenomatous polyps and non-adenomatous polyps, in order to provide evidence for th...
A retrospective, cross-sectional study was conducted at the First People's Hospital of Kunshan, Jiangsu, China. The study included 3028 adults who underwent abdominal ultrasonography and colonoscopy o...
A total of 65% of patients with NAFLD had colorectal polys (52% adenomatous polyps and 13% non-adenomatous polyps), and 40% of patients without NAFLD had polyps (29% adenomatous polyps and 11% non-ade...
NAFLD is associated with an increased risk of colorectal adenomatous polyps compared to the absence of polyps, but not associated with an increased risk of non-adenomatous polyps. These results provid...
The detection rate of dysplastic colorectal polyps has significantly increased with improved screening programs. Treatment of dysplastic polyps attempt to limit morbidity of a procedure while also con...
Post-polypectomy surveillance has proven to reduce colorectal cancer (CRC) incidence in patients with high-risk polyps, but it implies a major burden on colonoscopy units. Therefore, it should be targ...
Background: The aim of this study was to identify risk factors contributing to the malignancy of colorectal polyps, as well as risk factors for recurrence after the successful endoscopic mucosal resec...
A full colonoscopy is currently required in children and adolescents with colorectal polyps, because of their potential of neoplastic transformation and complications such as intussusception. We aimed...
Pediatric patients <18 years of age who had undergone a colonoscopic polypectomy and those with <5 colorectal polyps were included in this multicenter, retrospective study. Baseline clinicodemographic...
A total of 91 patients were included. Multivariate logistic regression analysis showed that polyp size was the only factor associated with the presence of any polyps located proximal to the splenic fl...
In children and adolescents presenting with <5 colorectal polyps, polyp size and the presence of any adenomatous polyp were positively associated with polyp location proximal to the splenic flexure. T...
It has not yet been determined whether gastroscopy and colonoscopy screening help patients with gallbladder diseases. We aim to retrospectively investigate the relationship between gallbladder disease...
This is a retrospective cross-sectional study involving 1662 patients who underwent gastroscopy, colonoscopy, and abdominal ultrasound as part of their health check-up from January 2015 to July 2020. ...
Patients with gallbladder polyps had greater odds of having colorectal polyps (adjusted odds ratio (OR)=1.77, 95% confidence interval [Cl]: 1.23 to 2.54, p=0.002) and gastric plus colorectal polyps (a...
Gallbladder polyps are significant indicators of colorectal and gastric plus colorectal polyps. Hence, gastroscopy and colonoscopy screening should be performed for patients with gallbladder polyps, p...